Mg. Tektonidou et al., Right ventricular diastolic dysfunction in patients with anticardiolipin antibodies and antiphospholipid syndrome, ANN RHEUM D, 60(1), 2001, pp. 43-48
Objective-To evaluate the prevalence of diastolic dysfunction in patients w
ith anticardiolipin antibodies (aCL) and to examine whether the antiphospho
lipid syndrome (APS) is associated with diastolic dysfunction independently
of valvular abnormalities and systolic dysfunction.
Methods-Pulsed, continuous, colour Doppler echocardiography was performed i
n 179 subjects, of whom 15 were excluded from the analysis because of systo
lic dysfunction or severe valvular disease. The remaining 164 subjects incl
uded 29 patients with primary APS, 26 patients with secondary APS (APS in t
he presence of systemic lupus erythematosus (SLE)), and 30 patients with SL
E and aCL but without BPS; 43 patients with SLE without aCL and 36 normal v
olunteers served as control groups.
Results-The groups compared differed significantly in all measures of right
ventricular function. There was a gradation of increasing diastolic functi
on impairment as manifested by prolonged deceleration time (DT) and isovolu
mic relaxation time (IVRT) across the groups of patients with SLE without a
CL, SLE with aCL, secondary APS, and primary APS. Differences in left ventr
icular diastolic function measures were less prominent. in regression analy
sis, DT increased by 19.6 ms (p=0.002) in the presence of primary APS and b
y 20.1 ms (p=0.038) in the presence of pulmonary hypertension. The titre of
IgG aCL was the strongest predictor of a prolonged IVRT.
Conclusion-Diastolic dysfunction, in particular of the right ventricle-that
is, independent of valvular disease and systolic dysfunction, is a promine
nt feature of APS and may be related to the pathogenesis of the syndrome.